Skip to main content
Premium Trial:

Request an Annual Quote

CDC: SARS PCR Tests Still Being Evaluated, More Viral Sequences Needed

NEW YORK, April 22 - PCR-based tests for the SARS coronavirus are being made by various labs, but the US Centers for Disease Control said today that they are still trying to determine, along with World Health Organization labs, the accuracy of these tests.


"There is a lot of interest in getting good testing protocols available for this agent," said Julie Gerberding, the CDC director, in a press conference this afternoon. Since the CDC and a Canadian team published their sequences online last week,   she acknowledged that "just about anybody with bio biotechnical capabilities" can create a PCR-based test from the sequence.


"The problem is knowing whether the test you are using is accurate or not," Gerberding said. "And the only way you can really determine that is by using that test on a wide variety of clinical specimens, including people that you are vary confident have the infection as well as people that you are very confident don't have the infection. And that takes time. But it also takes access to a whole panel of specimens."


The CDC has compared its SARS coronavirus sequence to that of the Canadian team, and has found few differences, Gerberding said. To shed light on why some people are getting sicker than others, "we need to sequence more viruses," she added. This "will be a longer term investigation."


Additionally, Gerberding said reports of a zoonotic connection to the SARS coronavirus are still at the level of "speculation,": So far no there is no evidence in sequence phylogeny for this connection.


Since the CDC and the Canadian team, at the British Columbia CancerCenter, announced the completion of their sequences early last week, teams inHong Kong, Singapore, andBeijinghave also published sequences online.


GenomeWeb coverage of SARS 
Canadian Team Sequencing SARS Virus  (Apr 9, 2003)

CDC Hails SARS Virus Sequencing, Discusses PCR Diagnostic Development   (Apr 14, 2003)

CDC Completes SARS Virus Genome Draft On Heels of Canadian Team  (April 14, 2003)

Canadian Team Leader: SARS Coronavirus Genome Has 11 Novel ORFs  (April 15, 2003)
CombiMatrix Creates Microarray Based on SARS Genome Data  (April 16, 2003)
Coronavirus Linked to SARS: WHO (April 16, 2003) 

Singapore Genome Institute Joins SARS Sequencing Fray (April 16, 2003)

Singapore Team Finishes SARS Virus Genome; Canadian Scientists Identify Viral Proteins (April 17, 2003)

Beijing Group Publishes Four SARS Sequences from Mainland China, Claims To Have One-Hour SARS Test (April 21, 2003)

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.